BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 15383636)

  • 1. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
    Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
    Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
    Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
    J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
    Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test.
    Dambisya YM; Lee TL
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):179-84. PubMed ID: 8046951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effects of choline against acute and inflammatory pain.
    Wang Y; Su DM; Wang RH; Liu Y; Wang H
    Neuroscience; 2005; 132(1):49-56. PubMed ID: 15780465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
    Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
    Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
    Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
    Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
    Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
    Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
    Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
    Smith GD; Smith MT
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
    Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.
    Al-Khrasani M; Lackó E; Riba P; Király K; Sobor M; Timár J; Mousa S; Schäfer M; Fürst S
    Brain Res Bull; 2012 Feb; 87(2-3):238-43. PubMed ID: 22079588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
    Gmerek DE; Cowan A; Woods JH
    J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses.
    Petrillo P; Angelici O; Bingham S; Ficalora G; Garnier M; Zaratin PF; Petrone G; Pozzi O; Sbacchi M; Stean TO; Upton N; Dondio GM; Scheideler MA
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1079-89. PubMed ID: 14551288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive properties of mixture of alpha-amyrin and beta-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways.
    Otuki MF; Ferreira J; Lima FV; Meyre-Silva C; Malheiros A; Muller LA; Cani GS; Santos AR; Yunes RA; Calixto JB
    J Pharmacol Exp Ther; 2005 Apr; 313(1):310-8. PubMed ID: 15626726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice.
    Valle L; Pol O; Puig MM
    J Pharmacol Exp Ther; 2001 Feb; 296(2):378-87. PubMed ID: 11160621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidural ketamine potentiates epidural morphine but not fentanyl in acute nociception in rats.
    Hoffmann VL; Baker AK; Vercauteren MP; Adriaensen HF; Meert TF
    Eur J Pain; 2003; 7(2):121-30. PubMed ID: 12600793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.